Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Networked Drug REpurposing for Mechanism-based neuroPrOtection in Ischaemic STROKE (REPO-STROKE IIa)

NCT05762146 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.

NCT NCT05762146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05762146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Ischaemic STROKE (REPO-STROKE IIa)
Lead sponsor
Maastricht University
Phase
Phase 2
Overall status
Unknown status
Start date
September 5, 2022
Completion date
April 30, 2024
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, acute